Fangzhou Inc. completes a HK$150 million share placement at HK$3.32 per share to boost investment in AI healthcare solutions. The company plans to use 90% of net proceeds for AI platform development, talent recruitment, data collection, and marketing. The fundraising follows a positive profit alert for 2025, with revenue expected to reach RMB 3.5-3.55 billion and net profit of RMB 7-10 million. Fangzhou aims to leverage AI for chronic disease management and support China’s “Healthy China 2030” initiative, drawing attention from institutional investors and global investment banks.

Read more at GlobeNewswire: Fangzhou Raises HK$150 Million in Share Placement to